Vera Therapeutics, Inc. (VERA) Misses Q3 EPS by 21c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $35.28 -1.7%
EPS Growth %: -27.8%
Financial Fact:
INCOME (LOSS) BEFORE TAXES: 20.17K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -27.8%
Financial Fact:
INCOME (LOSS) BEFORE TAXES: 20.17K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q3 EPS of ($0.91), $0.21 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Chime to acquire Stride Bank for $590M in cash
- Braze stock tumbles 10% on weak third quarter EPS guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
